Does a monoclonal antibody targeting immune cells affect glutamatergic level in schizophrenia? A multimodal PET/MRS brain imaging study.
- DOI
- 10.1038/s41386-026-02466-3
- Published
- 2026 Oct
- Container
- Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41386-026-02466-3,
title = {Does a monoclonal antibody targeting immune cells affect glutamatergic level in schizophrenia? A multimodal PET/MRS brain imaging study.},
author = {Hindley G and Mizuno Y and Beck K and Carreira Figueiredo I and Pillinger T and Jeljeli S and Dunn J and Hammers A and Awais R and Sander K and Årstad E and Lythgoe DJ and Schubert JJ and Veronese M and Turkheimer F and Howes OD and Reis Marques T},
year = {2026},
journal = {Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology},
doi = {10.1038/s41386-026-02466-3},
url = {https://doi.org/10.1038/s41386-026-02466-3}
}RIS
TY - JOUR TI - Does a monoclonal antibody targeting immune cells affect glutamatergic level in schizophrenia? A multimodal PET/MRS brain imaging study. AU - Hindley G AU - Mizuno Y AU - Beck K AU - Carreira Figueiredo I AU - Pillinger T AU - Jeljeli S AU - Dunn J AU - Hammers A AU - Awais R AU - Sander K AU - Årstad E AU - Lythgoe DJ AU - Schubert JJ AU - Veronese M AU - Turkheimer F AU - Howes OD AU - Reis Marques T PY - 2026 JO - Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology DO - 10.1038/s41386-026-02466-3 UR - https://doi.org/10.1038/s41386-026-02466-3 ER -
APA
G, H., Y, M., K, B., I, C. F., T, P., S, J., J, D., A, H., R, A., K, S., E, Å., DJ, L., JJ, S., M, V., F, T., OD, H., & T, R. M. (2026). Does a monoclonal antibody targeting immune cells affect glutamatergic level in schizophrenia? A multimodal PET/MRS brain imaging study.. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. https://doi.org/10.1038/s41386-026-02466-3
Source records
- pubmed · retrieved 2026-09-26T03:31:54.975Z